Erasca, Inc. (ERAS) vs LifeStance Health Group, Inc. (LFST)
A side-by-side comparison of Erasca, Inc. and LifeStance Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ERAS
Erasca, Inc.
$14.30HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LFST
LifeStance Health Group, Inc.
$12.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ERAS vs LFST
growth of $100 · dividends reinvested · last 5yERAS -15.5% (-3.3%/yr)LFST -53.0% (-14.0%/yr)ERAS compounded faster over this window
ERAS LFST
ERAS vs LFST: by the numbers
- •ERAS is the larger company ($4.96B vs $4.70B market cap).
- •LFST is profitable (3.19% net margin) while ERAS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ERAS | LFST |
|---|---|---|
| P/E ratio | N/A | 93.45 |
| Forward P/E | N/A | 75.50 |
| P/S ratio | N/A | 2.97 |
| P/B ratio | 13.72 | 3.18 |
| EV / EBITDA | N/A | 35.16 |
| FCF yield | N/A | 3.70% |
Profitability
| Metric | ERAS | LFST |
|---|---|---|
| Gross margin | 0.00% | 33.56% |
| Operating margin | 0.00% | 4.95% |
| Net margin | 0.00% | 3.19% |
| ROE | -79.37% | 3.43% |
| ROIC | -38.03% | 3.03% |
Growth (annualized)
| Metric | ERAS | LFST |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 24.79% |
| Total return CAGR (5Y) | -8.34% | -1.46% |
Frequently asked
- Is ERAS or LFST more profitable?
- LFST runs the higher net margin — ERAS at 0.00% versus LFST at 3.19%.
- How have ERAS and LFST total returns compared?
- Over the past 5 years, ERAS delivered -8.34% and LFST delivered -1.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LifeStance Health P/E ratioErasca ROELifeStance Health ROEErasca operating marginLifeStance Health operating marginErasca revenue growthLifeStance Health revenue growthErasca free cash flowLifeStance Health free cash flow
Erasca & LifeStance Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.